Reassessing medical risk in living kidney donors

J Am Soc Nephrol. 2015 May;26(5):1017-9. doi: 10.1681/ASN.2014030227. Epub 2014 Sep 25.

Abstract

The short- and long-term effects of unilateral nephrectomy on living donors have been important considerations for 60 years. Short-term risk is well established (0.03% mortality and <1% risk of major morbidity), but characterization of long-term risk is evolving. Relative to the general population, risk of mortality, ESRD, hypertension, proteinuria, and cardiovascular disease is comparable or lower. However, new studies comparing previous donors with equally healthy controls indicate increased risk of metabolic derangements (particularly involving calcium homeostasis), renal failure, and possibly, mortality. We discuss how these results should be interpreted and their influence on the practice of living donor kidney transplantation.

Keywords: ESRD; kidney transplantation; living donor; mortality risk.

MeSH terms

  • Humans
  • Kidney Transplantation*
  • Living Donors*
  • Nephrectomy / adverse effects*
  • Risk Assessment